Search research articles
Contact Us
Filters
Showing results (181-190 of 315) with videos related to
Page
of 32
Sort By:
Parkinsonism & Related Disorders
|
July 2, 2008
The role of the Lewy body in idiopathic Parkinsonism
R de la Fuente-Fernandez, M Schulzer, E Mak, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 1, 1997
"Familial Parkinson's disease"--a case-control study of families
R J Uitti, H Shinotoh, M Hayward, et al.
Nature
|
February 8, 1974
Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition
M Sandler, R D Johnson, C R Ruthven, et al.
Archives of Neurology
|
December 1, 1978
Effect of an opiate antagonist on movement disorders
J G Nutt, A J Rosin, T Eisler, et al.
Neurology
|
October 1, 1981
Prolactin secretion in Parkinson disease
T Eisler, M O Thorner, R M MacLeod, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1980
CFS hydroxylase cofactor levels in some neurological diseases
A C Williams, R A Levine, T N Chase, et al.
Ophthalmology
|
December 1, 1989
A retinopathy on Guam with high prevalence in Lytico-Bodig
T A Cox, J V McDarby, L Lavine, et al.
Parkinsonism & Related Disorders
|
July 27, 2001
The long-term response to levodopa in dopa-responsive dystonia
W J Hwang, D B Calne, J K Tsui, et al.
Advances in Neurology
|
January 1, 1975
Dopaminergic agonists in Parkinsonism
L E Claveria, P F Teychenne, D B Calne, et al.
Clinical Science
|
July 1, 1971
Cardiovascular reflexes in Parkinsonism
J L Reid, D B Calne, C F George, et al.
Page
of 32
Search research articles
Search
Showing results (181-190 of 315) with videos related to
Sort By:
Page
of 32
Parkinsonism & Related Disorders
|
July 2, 2008
The role of the Lewy body in idiopathic Parkinsonism
R de la Fuente-Fernandez, M Schulzer, E Mak, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 1, 1997
"Familial Parkinson's disease"--a case-control study of families
R J Uitti, H Shinotoh, M Hayward, et al.
Nature
|
February 8, 1974
Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition
M Sandler, R D Johnson, C R Ruthven, et al.
Archives of Neurology
|
December 1, 1978
Effect of an opiate antagonist on movement disorders
J G Nutt, A J Rosin, T Eisler, et al.
Neurology
|
October 1, 1981
Prolactin secretion in Parkinson disease
T Eisler, M O Thorner, R M MacLeod, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1980
CFS hydroxylase cofactor levels in some neurological diseases
A C Williams, R A Levine, T N Chase, et al.
Ophthalmology
|
December 1, 1989
A retinopathy on Guam with high prevalence in Lytico-Bodig
T A Cox, J V McDarby, L Lavine, et al.
Parkinsonism & Related Disorders
|
July 27, 2001
The long-term response to levodopa in dopa-responsive dystonia
W J Hwang, D B Calne, J K Tsui, et al.
Advances in Neurology
|
January 1, 1975
Dopaminergic agonists in Parkinsonism
L E Claveria, P F Teychenne, D B Calne, et al.
Clinical Science
|
July 1, 1971
Cardiovascular reflexes in Parkinsonism
J L Reid, D B Calne, C F George, et al.
Page
of 32